InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,714.00
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.16
(
-0.07%
)
Bitcoin
61,899.14
(
-1.60%
)
Post# of 285888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

SSP

Send PM Follow Ignore
Followers 642
Posts 44676
Boards Moderated 3
Alias Born 08/02/2000

SSP

Member Level

Re: gdog post# 254899

Monday, 09/22/2014 11:33:19 AM

Monday, September 22, 2014 11:33:19 AM

Post# of 285888
ZGNX - sNDA application to be filed next month:

Following a recent meeting with the U.S. Food and Drug Administration (FDA), Zogenix expects to file a supplemental new drug application (sNDA) by October 2014 for a next-generation formulation of Zohydro ER Extended-Release Capsules designed to make it more difficult to abuse by injection or nasal administration.

http://ir.zogenix.com/phoenix.zhtml?c=220862&p=irol-newsArticle&ID=1944452&highlight=
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up